Filing Flows › Ideaya Biosciences (IDYA) › Q2 2026 › vs Q1 2026
Ideaya Biosciences (IDYA) Q2 2026 vs Q1 2026 (quarter over quarter)
Ideaya Biosciences's revenue rose $2.3M (+35%) from $6.6M in Q1 2026 to $8.9M in Q2 2026.
Ideaya Biosciences, Q2 2026: revenue $8.9M, net loss $112M, operating cash flow −$88.2M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $8.9M | $6.6M | $2.3M | +35% |
| Other income, net | $9.8M | $10.0M | −$166K | -2% |
| Net loss | $112M | $98.5M | $13.9M | +14% |
| Costs & expenses | $131M | $115M | $16.0M | +14% |
| Operating costs | $131M | $115M | $16.0M | +14% |
| Research & development | $109M | $95.7M | $13.0M | +14% |
| General & admin | $22.5M | $19.4M | $3.1M | +16% |
| Operating cash sources | $112M | $98.5M | $13.9M | +14% |
| Depreciation & amortization | $688K | $688K | $0 | 0% |
| Share-based compensation | $16.7M | $14.5M | $2.1M | +15% |
| Working capital & other | $6.9M | $8.1M | −$1.2M | -15% |
| Cash used in operations | $88.2M | $75.2M | $13.0M | +17% |
| Net loss absorbed | $112M | $98.5M | $13.9M | +14% |
Questions
How much did Ideaya Biosciences's revenue grow quarter over quarter in Q2 2026?
Ideaya Biosciences's revenue rose $2.3M (+35%) from $6.6M in Q1 2026 to $8.9M in Q2 2026.